Samar Ali Abdalrazig Ali

  • Country of Origin: Sudan
  • Home University: National Ribat University
  • Host University & Country: University of Bradford - United Kingdom
  • PhD Title: Development of anti-malarial drug combinations with an immunity modulation approach for management of drug resistance
  • Year of Completion: 2027
Samar Ali Abdalrazig Ali

PhD Overview

The project aims to combine known immunity-booster, thymoquinone, and its derivatives (a chief ingredient in black cumin, which has both immunity-booster and anti-malarial properties) with the antimalarial using Pharmaceutical Engineering Technologies (Cocrystal and Peptide hydrogel formulation), to develop anti-malarial drug combinations drugs with superior physical and pharmacological properties for the management of drug resistance.

Sustainability Goals

  • Good Health and Well-being
  • Industry, Innovation and Infrastructure
  • Responsible Consumption and Production

About Me

Postgraduate researcher in antimalarial drug development with multiple conference presentations. Winner of the 3MT competition and Best Poster Award. Recognised with the Postgraduate Community Leader Award and highest-level Kickstart Award for my roles as PGR Representative and STEMinism Society officer. Active leader in women-in-STEM advocacy.